Inhibikase Therapeutics (IKT) Stock Chart & Stock Price History $1.83 -0.11 (-5.67%) As of 12:15 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Inhibikase Therapeutics Stock Price Performance 5 Day Performance-18.67%1 Month Performance+8.93%3 Month Performance-22.13%6 Month Performance-34.17%Year-To-Date Performance-43.69%1 Year Performance+45.24% Receive IKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address IKT Stock Chart for Wednesday, May, 7, 2025 IKT Chart by TradingView Inhibikase Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/06/2025$2.09$1.94-7.18%$2.09$1.94131,358 shs$144.22 million05/05/2025$2.25$2.09-7.11%$2.30$2.0865,194 shs$155.38 million05/02/2025$2.24$2.25+0.45%$2.37$2.20116,487 shs$167.27 million05/01/2025$2.26$2.24-0.88%$2.31$2.2149,845 shs$166.53 million04/30/2025$2.25$2.26+0.44%$2.30$2.16131,592 shs$168.01 million04/29/2025$2.20$2.25+2.27%$2.26$2.13131,460 shs$167.27 million04/28/2025$2.11$2.20+4.27%$2.20$2.09136,608 shs$163.55 million04/25/2025$2.26$2.11-6.64%$2.23$2.1093,404 shs$156.86 million04/24/2025$2.16$2.26+4.63%$2.26$2.11103,590 shs$168.01 million04/23/2025$1.96$2.16+10.20%$2.18$2.01112,002 shs$160.58 million Get the Latest News and Ratings for IKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/22/2025$1.89$1.96+3.70%$1.97$1.79128,002 shs$145.71 million04/21/2025$1.90$1.89-0.26%$1.90$1.7962,382 shs$140.51 million04/18/2025$1.90$1.90$1.98$1.84162,822 shs$140.88 million04/17/2025$1.98$1.90-4.29%$1.98$1.84162,822 shs$140.88 million04/16/2025$1.90$1.98+4.21%$1.98$1.85123,459 shs$147.20 million04/15/2025$2.00$1.90-5.00%$2.10$1.89111,294 shs$141.25 million04/14/2025$2.07$2.00-3.38%$2.22$1.97190,252 shs$148.68 million04/11/2025$1.86$2.07+11.29%$2.08$1.87105,774 shs$153.89 million04/10/2025$1.89$1.86-1.59%$1.98$1.7392,905 shs$138.28 million04/09/2025$1.66$1.89+13.86%$1.95$1.58212,330 shs$140.51 million04/09/2025$1.66$1.89+13.86%$1.95$1.58212,330 shs$140.51 million04/08/2025$1.68$1.66-1.19%$1.79$1.6184,277 shs$123.41 million04/08/2025$1.68$1.66-1.19%$1.79$1.6184,277 shs$123.41 million04/07/2025$1.84$1.68-8.70%$1.81$1.54352,589 shs$124.90 million Related Companies ANAB Stock Price Chart KALV Stock Price Chart ABUS Stock Price Chart TRVI Stock Price Chart CDXC Stock Price Chart PHAR Stock Price Chart ORGO Stock Price Chart CRMD Stock Price Chart BCYC Stock Price Chart IMTX Stock Price Chart Receive IKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:IKT) was last updated on 5/7/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibikase Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibikase Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IKT Stock Free IKT Stock Alerts